期刊文献+

MKK4蛋白在鼻咽癌组织中的表达及临床意义 被引量:4

Expression of MKK4 protein in nasopharyngeal carcinoma and their clinical significances
下载PDF
导出
摘要 目的:探讨MKK4蛋白在鼻咽癌组织中的表达及临床意义。方法:采用免疫组化方法分别检测90例鼻咽癌组织和20例鼻咽慢性炎症组织中MKK4蛋白的表达情况,并分析与鼻咽癌临床病理特征的关系。结果:MKK4蛋白在鼻咽癌组织中阳性表达率为75.6%(68/90),鼻咽慢性炎症组织中阳性表达率为95.5%(19/20),差异有统计学意义(P<0.05)。MKK4蛋白在有淋巴结转移、分化程度较差的组织中的高表达率明显低于无淋巴结转移、分化程度相对较好的组织(P<0.05),但不同年龄、性别、原发部位、T分期并不影响MKK4蛋白的阳性高表达率,无统计学差异(P>0.05)。结论:MKK4在鼻咽癌组织中的表达明显低于鼻咽慢性炎症组织中的表达,差异具有统计学意义;MKK4蛋白在有淋巴结转移、分化程度较差和临床分期较晚的组织中的表达明显低于无淋巴结转移、分化程度较好及临床分期较早的组织,差异具有显著性;但年龄、性别、原发部位、T分期在鼻咽癌组织中MKK4蛋白的表达均无显著性差异。 Objective:To investigate the expression of MKK 4 protein in the nasopharyngeal carcinoma and its clinical significance.Methods:Immunohistochemical methods were employed to analyze MKK 4 positive expression intensity and positive cells in freshly collected nasopharyngeal carcinoma of both 90nasopharyngeal carcinoma cases and 20 chronic nasopharyngitis control.The clinical pathological characteristic were analyzed.Results:The data obtained by MKK4 immunohistochemistry showed that the MKK 4 positive rate was higher in control group than in the NPC group (95.5%vs 75.6%,P〈0.05).The expression of MKK4 was related to tumor differentiation and lymph node metastasis ( P〈0.05 ) , but not to gender , age, tumor volum and TNM stage ( P〉0.05 ) . Conclusion:Positive rate of MKK4 protein in nasopharyngeal carcinoma tissues is lower than in chronic nasopharyngitis.MKK4 protein expressions in nasopharyngeal carcinoma tissues negatively correlated with lymph node metastasis ,clincal stage ,invasive depth ,and TTP (Time to progression),but not with age,gender,location and tumor volume.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第9期1235-1238,共4页 Chinese Journal of Immunology
基金 湖北省自然基金面上项目(2014CFB675) 湖北省教育厅重点项目(D20141205) 2012年宜昌市科技研究与开发项目(A12301-03)
关键词 鼻咽癌 MKK4蛋白 免疫组化 Nasopharyngeal carcinoma MKK4 protein Immunohistochemistry
  • 相关文献

参考文献13

  • 1Lin A, Minden A, Martinetto H, et al. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2 [ J ]. Science, 1995,268 (5208) :286-290.
  • 2鲁明骞,孔庆志.丝裂原活化蛋白激酶信号传导通路在恶性肿瘤中的研究现状[J].实用癌症杂志,2013,28(3):320-321. 被引量:9
  • 3Hickson JA, Huo D, Vander Griend DJ, et al. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma[ J]. Cancer Res,2006,66(4) :2264-2270.
  • 4Whitmarsh A J, Davis RJ. Role of mitogen-activated protein kinase kinase 4 in cancer[J]. Oncogcne,2007,26(22) :3172-3184.
  • 5刘斌,黄斌芳,杨磊,吕嘉春.EB病毒-MKK4基因遗传变异的交互作用与鼻咽癌危险性研究[J].实用医学杂志,2012,28(2):175-177. 被引量:5
  • 6Teng DH, Perry lii WL, Hogan JK, et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor [ J ]. Cancer Res, 1997,57 (19) :4177-4182.
  • 7Cunningham SC, Kamangar F, Kim MP,et al. MKK4 status predicts survival after resection of gastric adenocarcinoma [ J ]. Arch Surg, 2006,141 ( 11 ) : 1095-1099.
  • 8Stark AM, Tongers K, Maass N, et al. Reduced metastasis- suppressor gene mRNA-expression in breast cancer brain metastases [ J ]. J Cancer Res Clin Oncol, 2005,131 ( 3 ) : 191-198.
  • 9Wang L, Pan Y, Dai JL. Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors [ J ]. Oncogene, 2004,23 ( 35 ) : 5978-5985.
  • 10Wu CW, Li AF, Chi CW, et al. Human gastric cancer kinase profile and prognostic significance otMKK4 kinase [ J ]. Am J Pathol, 2000,56 ( 6 ) : 2007 -2015.

二级参考文献26

  • 1Morris M A, Dawson C W, Young L S. Role of the Epstein- Barr virus-encoded latent membrane protein-l, LMP1, in the pathogenesis of nasopharyngeal carcinoma [J]. Future Oncol, 2009,5(6) :811-825.
  • 2Kutz H, Reisbach G, Schultheiss U, et al. The c-Jan N- terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus [J]. Virology, 2008,371 (2) : 246-256.
  • 3Zou H, Li Q, Lin SC, et al. Differential requirement of MKK4 and MKK7 in JNK activation by distinct scaffold proteins [ J ]. FEBS Lett, 2007,581 (2) : 196-202.
  • 4Liu B, Chen D, Yang L, et al. A functional variant (-1304T>G) in the MKK4 promoter contributes to a decreased risk of lung cancer by increasing the promoter activity [J]. Carcinogenesis, 2010,31(8) : 1405-1411.
  • 5Sturgis E M, Castillo E J, Li L, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck [J]. Carcinogenesis, 1999,20( 1 ) : 2125-2129.
  • 6Chae K S, Ryu B K, Lee M G, et al. Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma [J]. Eur J Cancer, 2002,38(15) :2048-2057.
  • 7Cunningham S C, Hucl T, Dezentje D A, et al. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss [J]. Cancer Res, 2006,66( 11 ) : 5560-5564.
  • 8Spillman, M A, Lacy J, Murphy S K, et al. Regulation of the metastasis suppressor gene MKK4 in ovarian cancer [J]. Gynecol Oncol, 2007,105 (2) : 312-320.
  • 9Wei Y, Wang L, Lan P, et al. The association between- 13(MT>G polymorphism in the promoter of MKK4 gene and the risk of sporadic colorectal cancer in southern Chinese population [J]. Int J Cancer, 2009,125(8) : 1876-1883.
  • 10Dong X, Liu Y, Du M, et al. P38 mitogen-activated protein kinase in- hibition attenuates pulmonary inflammatory response in a rat cardiop- ulmonary bypass model [ J ]. Eur J Cardiothorac Surg, 2006,30 ( 1 ) :77.

共引文献9

同被引文献45

  • 1Chen L, Hu CS, Chen XZ, et al. Concurrent chemoradiotherrapy plus adjuvant chemotherapy versus cencurrent chemotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: A plus 3 multicentre randomised controlled trial [ J ]. Lancet On- col, 2012,13(2) :163-171.
  • 2Taylor JL, Szmulewitz RZ, Lotan T, et al. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer ceils[ J]. Cancer Lett, 2008,272( 1 ) :12-22.
  • 3Tang KF, Tan SY, Chan SH, et al. A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implica-tion for the intense tumor infiltration by T lymphocytes and macro- phages[ J]. Hum Pathol, 2001,32( 1 ) :42-49.
  • 4Whitmarsh A J, Davis RJ. Role of mitogen-activated protein kinase kinase 4 incaneer[J]. Oncogene, 2007,26(22) :3172-3184.
  • 5Wuestefeld T, Pesic M, Rudalska R, et al. A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration[ J]. Cell, 2013,153(2) :389-401.
  • 6An J, Liu H, Magyar CE, et al. Hyperactivated JNK is a thera- peutic target in pVHL-deficient renal cell carcinoma [ J ]. Cancer Res, 2013,73 (4) : 1374-1385.
  • 7Khamis ZI, Iczkowski KA, Sang QX. Metastasis suppressors in hu- man benign prostate, intraepithelial neoplasia, and invasive canc- er: their prospects as therapeutic agents[ J]. Med Res Rev, 2012, 32(5 ) : 1026-1077.
  • 8Divya SP, Wang X, Pratheeshkumar P, et al. Blackberry extract inhibits UVB-induced oxidative damage and inflammation through MAP kinases and NF-κB signaling pathways in SKH-1 mice skin [ J]. Son YOToxicol Appl Pharmacol, 2015,284( 1 ) :92-99.
  • 9Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD) [J]. Lancet Oncol, 2008,9(8) :730-756.
  • 10Bozdogan O, Yulug IG, Vargel I, et al. Differential expression patterns of metastasis suppressor proteins in basal cell carcinoma [J]. Int J Dermatol, 2015,54(8) :905-915.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部